Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis

scientific article published on 23 January 2018

Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0191465
P932PMC publication ID5779662
P698PubMed publication ID29360841

P50authorOlalekan A. UthmanQ38304685
P2093author name stringAndrew J Sutton
Louise J Jackson
Rashidah T Uthman
P2860cites workThe half-cycle correction revisited: redemption of a kludge.Q51594825
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.Q51931076
Deriving a preference-based single index from the UK SF-36 Health Survey.Q52231497
Treatment Supporter to Improve Adherence to Antiretroviral Therapy in HIV-Infected South African AdultsQ57235736
Decision-analytical modelling in health-care economic evaluationsQ57742559
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAARTQ58106373
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reportingQ61860180
Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing worldQ80590446
Cost-effectiveness of highly active antiretroviral therapy in South AfricaQ24814698
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsQ29547281
Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trialQ30497684
HIV prevention cost-effectiveness: a systematic reviewQ30892555
The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant womenQ33559823
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic reviewQ33616453
Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trialsQ33707616
Development of WHO guidelines on generalized cost-effectiveness analysisQ33903387
Methods to assess the costs and health effects of interventions for improving health in developing countriesQ34131989
Trust and the acceptance of and adherence to antiretroviral therapyQ34386664
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyQ34656852
Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South AfricaQ35120904
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisQ36560027
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panelQ37234205
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trialsQ37642979
The provider cost of treating tuberculosis in Bauchi State, NigeriaQ37693149
Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settingsQ38882906
The estimation of a preference-based measure of health from the SF-36.Q40647897
Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitusQ44035730
The half-cycle correction explained: two alternative pedagogical approachesQ44948886
A meta-analysis of utility estimates for HIV/AIDS.Q46061609
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectSub-Saharan AfricaQ132959
value for moneyQ106909305
P304page(s)e0191465
P577publication date2018-01-23
P1433published inPLOS OneQ564954
P1476titleDoes directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis
P478volume13

Reverse relations

Q59353323Optimal Information Collection Policies in a Markov Decision Process Frameworkcites workP2860

Search more.